HEADER STRUCTURAL PROTEIN 01-JUL-08 3DMW TITLE CRYSTAL STRUCTURE OF HUMAN TYPE III COLLAGEN G982-G1023 CONTAINING C- TITLE 2 TERMINAL CYSTINE KNOT COMPND MOL_ID: 1; COMPND 2 MOLECULE: COLLAGEN ALPHA-1(III) CHAIN; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: UNP RESIDUES 1158-1199; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: CHEMICALLY SYNTHESIZED PEPTIDE G982-G1023 BASED ON SOURCE 4 THE FRAGMENT 1158-1199 OF THE HUMAN COLLAGEN ALPHA-1(III) CHAIN, SOURCE 5 CO3A1_HUMAN, UNIPROT ENTRY P02461. KEYWDS COLLAGEN III, CYSTINE KNOT, TRIPLE HELIX, GLYCINE, MAD PHASING, KEYWDS 2 ALTERNATIVE SPLICING, DISEASE MUTATION, EHLERS-DANLOS SYNDROME, KEYWDS 3 EXTRACELLULAR MATRIX, GLYCOPROTEIN, HYDROXYLATION, PHOSPHOPROTEIN, KEYWDS 4 POLYMORPHISM, SECRETED, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.P.BOUDKO,J.ENGEL,K.OKUYAMA,K.MIZUNO,H.P.BACHINGER,M.A.SCHUMACHER REVDAT 4 20-OCT-21 3DMW 1 SEQADV LINK REVDAT 3 05-JAN-10 3DMW 1 JRNL REVDAT 2 24-FEB-09 3DMW 1 VERSN REVDAT 1 30-SEP-08 3DMW 0 JRNL AUTH S.P.BOUDKO,J.ENGEL,K.OKUYAMA,K.MIZUNO,H.P.BACHINGER, JRNL AUTH 2 M.A.SCHUMACHER JRNL TITL CRYSTAL STRUCTURE OF HUMAN TYPE III COLLAGEN GLY991-GLY1032 JRNL TITL 2 CYSTINE KNOT-CONTAINING PEPTIDE SHOWS BOTH 7/2 AND 10/3 JRNL TITL 3 TRIPLE HELICAL SYMMETRIES. JRNL REF J.BIOL.CHEM. V. 283 32580 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18805790 JRNL DOI 10.1074/JBC.M805394200 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 843794.430 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.6 REMARK 3 NUMBER OF REFLECTIONS : 3949 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.248 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.800 REMARK 3 FREE R VALUE TEST SET COUNT : 425 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.015 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 623 REMARK 3 BIN R VALUE (WORKING SET) : 0.3470 REMARK 3 BIN FREE R VALUE : 0.3470 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 52 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.048 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 740 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 61 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -9.64000 REMARK 3 B22 (A**2) : -7.59000 REMARK 3 B33 (A**2) : 17.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 15.88000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM SIGMAA (A) : 0.33 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.42 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.440 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 24.51 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP9.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN4.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3DMW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1000048236. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000, 0.979, 1.02, 0.97963 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 3964 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 34.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : 0.07500 REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.24000 REMARK 200 R SYM FOR SHELL (I) : 0.24000 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 550, PH 7.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 10.76000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE PEPTIDE ASSEMBLES INTO A TRIPLE HELIX (3 CHAINS OF THE REMARK 300 42-MER) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 PRO A 2 REMARK 465 CYS A 40 REMARK 465 GLY A 41 REMARK 465 GLY A 42 REMARK 465 GLY B 1 REMARK 465 PRO B 2 REMARK 465 ILE B 3 REMARK 465 GLY B 41 REMARK 465 GLY B 42 REMARK 465 GLY C 1 REMARK 465 CYS C 39 REMARK 465 CYS C 40 REMARK 465 GLY C 41 REMARK 465 GLY C 42 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 4 N - CA - C ANGL. DEV. = -18.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL DBREF 3DMW A 1 42 UNP P02461 CO3A1_HUMAN 1158 1199 DBREF 3DMW B 1 42 UNP P02461 CO3A1_HUMAN 1158 1199 DBREF 3DMW C 1 42 UNP P02461 CO3A1_HUMAN 1158 1199 SEQADV 3DMW MSE A 26 UNP P02461 GLN 1183 ENGINEERED MUTATION SEQADV 3DMW MSE B 26 UNP P02461 GLN 1183 ENGINEERED MUTATION SEQADV 3DMW MSE C 26 UNP P02461 GLN 1183 ENGINEERED MUTATION SEQRES 1 A 42 GLY PRO ILE GLY PRO HYP GLY PRO ARG GLY ASN ARG GLY SEQRES 2 A 42 GLU ARG GLY SER GLU GLY SER HYP GLY HIS HYP GLY MSE SEQRES 3 A 42 HYP GLY PRO HYP GLY PRO HYP GLY ALA HYP GLY PRO CYS SEQRES 4 A 42 CYS GLY GLY SEQRES 1 B 42 GLY PRO ILE GLY PRO HYP GLY PRO ARG GLY ASN ARG GLY SEQRES 2 B 42 GLU ARG GLY SER GLU GLY SER HYP GLY HIS HYP GLY MSE SEQRES 3 B 42 HYP GLY PRO HYP GLY PRO HYP GLY ALA HYP GLY PRO CYS SEQRES 4 B 42 CYS GLY GLY SEQRES 1 C 42 GLY PRO ILE GLY PRO HYP GLY PRO ARG GLY ASN ARG GLY SEQRES 2 C 42 GLU ARG GLY SER GLU GLY SER HYP GLY HIS HYP GLY MSE SEQRES 3 C 42 HYP GLY PRO HYP GLY PRO HYP GLY ALA HYP GLY PRO CYS SEQRES 4 C 42 CYS GLY GLY MODRES 3DMW HYP A 6 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP A 21 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP A 24 PRO 4-HYDROXYPROLINE MODRES 3DMW MSE A 26 MET SELENOMETHIONINE MODRES 3DMW HYP A 27 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP A 30 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP A 33 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP A 36 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 6 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 21 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 24 PRO 4-HYDROXYPROLINE MODRES 3DMW MSE B 26 MET SELENOMETHIONINE MODRES 3DMW HYP B 27 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 30 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 33 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP B 36 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 6 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 21 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 24 PRO 4-HYDROXYPROLINE MODRES 3DMW MSE C 26 MET SELENOMETHIONINE MODRES 3DMW HYP C 27 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 30 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 33 PRO 4-HYDROXYPROLINE MODRES 3DMW HYP C 36 PRO 4-HYDROXYPROLINE HET HYP A 6 8 HET HYP A 21 8 HET HYP A 24 8 HET MSE A 26 8 HET HYP A 27 8 HET HYP A 30 8 HET HYP A 33 8 HET HYP A 36 8 HET HYP B 6 8 HET HYP B 21 8 HET HYP B 24 8 HET MSE B 26 8 HET HYP B 27 8 HET HYP B 30 8 HET HYP B 33 8 HET HYP B 36 8 HET HYP C 6 8 HET HYP C 21 8 HET HYP C 24 8 HET MSE C 26 8 HET HYP C 27 8 HET HYP C 30 8 HET HYP C 33 8 HET HYP C 36 8 HETNAM HYP 4-HYDROXYPROLINE HETNAM MSE SELENOMETHIONINE HETSYN HYP HYDROXYPROLINE FORMUL 1 HYP 21(C5 H9 N O3) FORMUL 1 MSE 3(C5 H11 N O2 SE) FORMUL 4 HOH *61(H2 O) SSBOND 1 CYS A 39 CYS B 40 1555 1555 2.04 LINK C PRO A 5 N HYP A 6 1555 1555 1.35 LINK C HYP A 6 N GLY A 7 1555 1555 1.33 LINK C SER A 20 N HYP A 21 1555 1555 1.34 LINK C HYP A 21 N GLY A 22 1555 1555 1.33 LINK C HIS A 23 N HYP A 24 1555 1555 1.34 LINK C HYP A 24 N GLY A 25 1555 1555 1.33 LINK C GLY A 25 N MSE A 26 1555 1555 1.33 LINK C MSE A 26 N HYP A 27 1555 1555 1.35 LINK C HYP A 27 N GLY A 28 1555 1555 1.33 LINK C PRO A 29 N HYP A 30 1555 1555 1.34 LINK C HYP A 30 N GLY A 31 1555 1555 1.33 LINK C PRO A 32 N HYP A 33 1555 1555 1.35 LINK C HYP A 33 N GLY A 34 1555 1555 1.33 LINK C ALA A 35 N HYP A 36 1555 1555 1.35 LINK C HYP A 36 N GLY A 37 1555 1555 1.33 LINK C PRO B 5 N HYP B 6 1555 1555 1.35 LINK C HYP B 6 N GLY B 7 1555 1555 1.33 LINK C SER B 20 N HYP B 21 1555 1555 1.35 LINK C HYP B 21 N GLY B 22 1555 1555 1.33 LINK C HIS B 23 N HYP B 24 1555 1555 1.34 LINK C HYP B 24 N GLY B 25 1555 1555 1.33 LINK C GLY B 25 N MSE B 26 1555 1555 1.33 LINK C MSE B 26 N HYP B 27 1555 1555 1.34 LINK C HYP B 27 N GLY B 28 1555 1555 1.33 LINK C PRO B 29 N HYP B 30 1555 1555 1.34 LINK C HYP B 30 N GLY B 31 1555 1555 1.33 LINK C PRO B 32 N HYP B 33 1555 1555 1.34 LINK C HYP B 33 N GLY B 34 1555 1555 1.33 LINK C ALA B 35 N HYP B 36 1555 1555 1.35 LINK C HYP B 36 N GLY B 37 1555 1555 1.33 LINK C PRO C 5 N HYP C 6 1555 1555 1.35 LINK C HYP C 6 N GLY C 7 1555 1555 1.33 LINK C SER C 20 N HYP C 21 1555 1555 1.34 LINK C HYP C 21 N GLY C 22 1555 1555 1.33 LINK C HIS C 23 N HYP C 24 1555 1555 1.34 LINK C HYP C 24 N GLY C 25 1555 1555 1.33 LINK C GLY C 25 N MSE C 26 1555 1555 1.33 LINK C MSE C 26 N HYP C 27 1555 1555 1.35 LINK C HYP C 27 N GLY C 28 1555 1555 1.33 LINK C PRO C 29 N HYP C 30 1555 1555 1.34 LINK C HYP C 30 N GLY C 31 1555 1555 1.33 LINK C PRO C 32 N HYP C 33 1555 1555 1.35 LINK C HYP C 33 N GLY C 34 1555 1555 1.33 LINK C ALA C 35 N HYP C 36 1555 1555 1.35 LINK C HYP C 36 N GLY C 37 1555 1555 1.33 CRYST1 31.980 21.520 68.970 90.00 92.58 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.031270 0.000000 0.001409 0.00000 SCALE2 0.000000 0.046468 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014514 0.00000 MASTER 254 0 24 0 0 0 0 6 0 0 0 12 END